234 related articles for article (PubMed ID: 9053510)
1. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.
Tanigawa N; Amaya H; Matsumura M; Shimomatsuya T
J Clin Oncol; 1997 Feb; 15(2):826-32. PubMed ID: 9053510
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
Takahashi Y; Kitadai Y; Bucana CD; Cleary KR; Ellis LM
Cancer Res; 1995 Sep; 55(18):3964-8. PubMed ID: 7664263
[TBL] [Abstract][Full Text] [Related]
3. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
4. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer.
Harada Y; Ogata Y; Shirouzu K
Int J Clin Oncol; 2001 Oct; 6(5):221-8. PubMed ID: 11723743
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
Winther H; Ahmed A; Dantzer V
Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
10. Co-localization of vascular endothelial growth factor and its two receptors flt-1 and kdr in the mink placenta.
Winther H; Dantzer V
Placenta; 2001 May; 22(5):457-65. PubMed ID: 11373156
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
13. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
14. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
16. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
17. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach.
Takahashi R; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(3):266-74. PubMed ID: 12697968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]